Dr Roland Kozlowski

Roland Kozlowski is a bioentrepreneur who has worked in the industry since the mid 90s with a reputation for creative solutions. Roland is CEO (and founder) of Lectus Therapeutics Ltd. Previously he was CEO of Sense Proteomic Ltd and prior to that worked with Oxford Molecular, notably on a key deal he negotiated with Astellas (then Yamanouchi). He has executed many transactions ranging from company sale, purchase, financing and in- and out-licensing. His research background is in pharmacology and, after a PhD at Cambridge, he ran research groups at Oxford and Bristol Universities where he is a Visiting Industrial Professor.

Roland has published extensively and is an inventor on granted patents. He is an non-executive director of London Genetics and has served on the BIA board and participates activity in policy formulation for UK biotech.